.png){kind=icon}
.png){kind=icon}
Return
DUSP26: Unveiling a critical molecular mediator and therapeutic target in developmental dysplasia of the hip-associated secondary osteoarthritis
.png){kind=icon}
PRE
AI
E
Z
D
S
X
DOI：10.3892/ijmm.2026.5776.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Secondary osteoarthritis, a degenerative joint disease, is often precipitated by well-characterized etiological factors, with developmental dysplasia of the hip (DDH) emerging as a leading contributor. Despite its clinical importance, the intricate molecular and cellular cascades triggered by the biomechanical perturbations associated with DDH remain poorly understood. In the present study, a swaddling-induced rat model of DDH was successfully developed, which recapitulated key pathological features including acetabular labral tears and cartilage degeneration. Through comprehensive mRNA-sequencing analysis of acetabular cartilage samples from rats with DDH, a notable upregulation of dual-specificity phosphatase 26 (DUSP26) was identified, a protein with previously unreported roles in joint homeostasis. Subsequently, in an in vitro inflammatory microenvironment induced by interleukin (IL)-1 beta, adenovirus-mediated overexpression of DUSP26 demonstrated marked chondroprotective effects. Specifically, this intervention led to a significant increase in the expression of type II collagen, a hallmark of healthy chondrocytes, while concurrently reducing the levels of catabolic markers such as type I collagen, TNF-alpha and IL-6. Reciprocally, adenovirus-delivered short hairpin RNA-mediated DUSP26 silencing exacerbated cartilage degradation, validating its protective function. Employing mass spectrometry-based proteomics combined with genetic and pharmacological approaches, the underlying mechanism was elucidated: DUSP26 overexpression exerted its chondroprotective effects by dephosphorylating and inactivating histone deacetylase (HDAC)1, HDAC2 and HDAC8, thereby maintaining chondrocyte integrity. Collectively, the findings of the present study underscore DUSP26 as a promising therapeutic target for DDH-associated osteoarthritis, offering novel mechanistic insights and laying the groundwork for the development of targeted interventions to mitigate secondary joint degeneration.
Keywords:
dual-specificity phosphatase 26
developmental dysplasia of the hip
osteoarthritis
cartilage degeneration
histone deacetylases
Journal
I
IF:
5.8
Papers:
5.7K
Citations:
1.7W
Organization
Cited Papers